See more : KPJ Healthcare Berhad (5878.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Global Medical REIT Inc. (GMRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Medical REIT Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- Domino’s Pizza Group plc (DMPZF) Income Statement Analysis – Financial Results
- Grenergy Renovables, S.A. (GRE.MC) Income Statement Analysis – Financial Results
- Elevance Health Inc. (ELV) Income Statement Analysis – Financial Results
- Materials Analysis Technology Inc. (3587.TWO) Income Statement Analysis – Financial Results
- Citizens, Inc. (CIA) Income Statement Analysis – Financial Results
Global Medical REIT Inc. (GMRE)
About Global Medical REIT Inc.
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 140.93M | 137.28M | 115.94M | 93.73M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380.41K | 0.00 | 0.00 |
Cost of Revenue | 86.22M | 25.19M | 15.49M | 10.87M | 5.96M | 3.72M | 1.86M | 1.43M | 1.02M | 360.00K | 0.00 | 0.00 |
Gross Profit | 54.72M | 112.10M | 100.45M | 82.86M | 64.77M | 49.47M | 28.36M | 6.65M | 1.04M | 20.41K | 0.00 | 0.00 |
Gross Profit Ratio | 38.82% | 81.65% | 86.64% | 88.41% | 91.58% | 93.01% | 93.85% | 82.25% | 50.54% | 5.36% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.15 | 0.17 | -0.03 | 0.14 | 0.27 | 0.00 | -0.77 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
Other Expenses | 0.00 | 56.72M | 46.88M | 36.35M | 24.64M | 17.27M | 121.00K | 130.78K | 659.67K | 129.08K | 0.00 | 0.00 |
Operating Expenses | 16.90M | 73.27M | 63.33M | 66.32M | 37.44M | 27.23M | 18.61M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Cost & Expenses | 103.11M | 98.46M | 78.82M | 77.18M | 43.40M | 30.95M | 20.47M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
Interest Income | 0.00 | 25.23M | 19.70M | 18.68M | 17.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 30.89M | 25.23M | 19.70M | 18.68M | 17.47M | 14.98M | 7.44M | 4.14M | 1.52M | 298.66K | 0.00 | 0.00 |
Depreciation & Amortization | 59.01M | 98.81M | 78.97M | 77.51M | 43.70M | 31.33M | 23.00M | 10.43M | 659.67K | 129.08K | 0.00 | 50.11K |
EBITDA | 111.64M | 96.49M | 84.00M | 53.00M | 50.82M | 40.20M | 17.35M | 2.48M | 569.53K | -224.46K | -45.34K | 0.00 |
EBITDA Ratio | 79.21% | 70.28% | 72.45% | 56.44% | 73.48% | 75.58% | 66.18% | 30.75% | 58.04% | -59.01% | 0.00% | 0.00% |
Operating Income | 37.94M | 38.83M | 37.12M | 16.55M | 27.33M | 22.24M | 7.35M | -2.21M | -1.52M | -652.21K | -45.34K | -50.11K |
Operating Income Ratio | 26.92% | 28.28% | 32.02% | 17.65% | 38.64% | 41.82% | 24.31% | -27.41% | -73.96% | -171.45% | 0.00% | 0.00% |
Total Other Income/Expenses | -16.20M | -18.83M | -18.78M | -30.77M | -17.47M | -7.68M | -9.96M | -6.33M | -2.13M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 21.73M | 20.00M | 18.34M | -2.50M | 9.59M | 14.56M | -87.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Income Before Tax Ratio | 15.42% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 25.23M | 20.42M | 18.11M | 17.83M | 1.07M | -49.00K | 4.27M | 1.52M | 597.33K | 0.00 | 50.11K |
Net Income | 20.61M | -5.23M | -2.07M | -20.61M | -8.24M | 13.49M | -38.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
Net Income Ratio | 14.63% | -3.81% | -1.79% | -21.98% | -11.65% | 25.36% | -0.13% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
EPS | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
EPS Diluted | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
Weighted Avg Shares Out | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Weighted Avg Shares Out (Dil) | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Global Medical REIT Inc. Board Declares 2024 Fourth Quarter Common and Preferred Dividends
1 REIT To Sell And 1 REIT To Buy
Capitalize On The Dip: Two Durable 9% Yields To Load Up Your Income Portfolio
Global Medical REIT: Cash Flow Tracking Lower Than 9.4% Dividend Yield
Global Medical REIT, Inc. (GMRE) Q3 2024 Earnings Call Transcript
Global Medical REIT (GMRE) Q3 FFO and Revenues Miss Estimates
Global Medical REIT Announces Third Quarter 2024 Financial Results
MOBs, Office But No Need For Life Support
The Ultimate Portfolio Structure For Stress-Free High Current Income
Global Medical REIT Inc. Announces Dates for Third Quarter Earnings Release and Webcast
Source: https://incomestatements.info
Category: Stock Reports